Pipeline
Autifony’s pipeline includes clinical stage programmes for Schizophrenia, age related hearing loss, Fragile X and earlier stage programmes focused on ALS and Alzheimer’s Disease.
Compound | Indication | Lead Optimization | Preclinical Development | Phase I | Phase II |
---|---|---|---|---|---|
AUT00201 (Kv3.1/Kv3.2) | Schizophrenia | ||||
AUT00206 (Kv3.1/Kv3.2) | Age Related Hearing Loss | ||||
Kv3.1/3.2 modulators | Fragile X, Chronic Pain | ||||
Novel ion channel | Amyotrophic Lateral Sclerosis | ||||
Novel Ion Channel | Alzheimer's Disease Frontotemporal Dementia |
Comments are closed.